Kwonyango lwezifo ezahlukileyo ezichaphazelayo, ezibangelwa yi-microbes pathogenic, isisombululo esinama-phagolysate oyinyumba ala ma microorganms asetyenziswa. Kwii-pharmacy, kukho iindidi ezi-2 zezobisi: i-pyobacteriophage eyinkimbinkimbi kunye ne-polyvalent-umahluko phakathi kwabo kunzima ukuphawula ngokukhawuleza, kungenxa yoko abaninzi abantu bafumana unyango olungalunganga.
Uthini umahluko phakathi kwe-pyobacteriophage eyinkimbinkimbi kunye ne-polyvalent?
Khangela umbahluko phakathi kwezilwanyana ezibhekiselwe kumbuzo kufuneka ube kwimimiselo, ngokukodwa - ufunde ngokucophelela ukubunjwa kwawo. Kwi-1 ml ye-polyvalent liquid piobacteriophage iqulethe umxube wee-filtrate ezihlanjululweyo ze-phagolysates ezi zilandelayo ze-pathogenic microorganms:
- streptococci ;
- proteus mirabilis kunye ne vulgaris;
- staphylococci;
- escherichia coli;
- Klebsiella pneumonia ;
- pseudomonas aeruginosis.
Ukuba sigxininisa ukubunjwa kwebhakteria ye-pyobacteriophage eyinkimbinkimbi, ngoko iqulethe iicandelo ezisebenzayo. Kodwa isisombululo siqukethe i-phagolysate oyinyumba ye-enterococci.
Akukho mfahluko omkhulu phakathi kwezenzo okanye ukuphumelela kwe-piobacteriophage ene-polyvalent and complex. Zomibini izidakamizwa zinokuluhlu olufanayo kwimiqondiso. Ukwahlukana kuphela kukuba ukuba eso sifo sibangelwa i-enterococci, isisombululo esinamaninzi asiyi kunceda.
Yintoni engcono ukuyithenga - i-pyobacteriophage eyinkimbinkimbi okanye eqhelekileyo?
Ngaphambi kokuba kuqeshwe nayiphi na imishanguzo enefuthe lokulwa ne-antimicrobial, kwenziwa uhlalutyo oluchonga ii-agents ezikhuselekileyo zezifo ezikhoyo, kunye nobuzwe babo kwiziyobisi ezahlukeneyo.
Ukufaneleka kokuthenga ibritriophage ethile kumiselwe ngugqirha. Ukuba i-pathology iyashukunyiswa yi-enterococci, kungcono ukuthatha isisombululo esinzima.